Mt. Olympus Medical Research
Welcome,         Profile    Billing    Logout  
 0 Trials 
9 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soto, Efrain
NCT05490680: A New Sildenafil Oral Film in Patients With Erectile Dysfunction

Recruiting
3
488
US
Sildenafil Oral Film 25 mg, 50 mg, 75 mg or 100 mg, Sildenafil Orodispersible Film, Placebo, Placebo-controlled
IBSA Institut Biochimique SA
Erectile Dysfunction
10/24
12/24
NCT04759833: A Study of Prucalopride For Functional Constipation in Children and Teenagers

Terminated
3
175
US
Prucalopride, TAK-555, Prucalopride succinate, Placebo
Takeda, Takeda Development Center Americas, Inc.
Constipation
11/23
11/23
PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Active, not recruiting
3
9541
Europe, Canada, Japan, US, RoW
Obicetrapib, Placebo
NewAmsterdam Pharma, Monash University
Atherosclerotic Cardiovascular Disease
11/26
11/26
NCT04627272: AutoDx-DR Prospective Clinical Validation Study Protocol

Not yet recruiting
N/A
1539
NA
AutoDX-DR
Hill-Rom, Rho, Inc., ClinEdge
Diabetic Retinopathy
07/21
07/21
NCT05808699: Camera Qualification Study

Active, not recruiting
N/A
565
US
handheld fundus camera
Digital Diagnostics, Inc., Fortrea
Diabetic Retinopathy
03/24
11/24
SHIELD, NCT05117840: Screening for High Frequency Malignant Disease

Recruiting
N/A
9000
Europe, US
Low-dose CT scan
Guardant Health, Inc.
Lung Cancer
12/24
12/25
NCT05569005: Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms.

Recruiting
N/A
1895
Europe, Japan, US, RoW
THS use, Tobacco Heating System 3.0, Cigarette, Smoking Abstinence
Philip Morris Products S.A.
COPD, Smoking, Tobacco Use
09/25
06/27
Baeza, Astrid
SHIELD, NCT05117840: Screening for High Frequency Malignant Disease

Recruiting
N/A
9000
Europe, US
Low-dose CT scan
Guardant Health, Inc.
Lung Cancer
12/24
12/25
Singal
PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Active, not recruiting
3
9541
Europe, Canada, Japan, US, RoW
Obicetrapib, Placebo
NewAmsterdam Pharma, Monash University
Atherosclerotic Cardiovascular Disease
11/26
11/26

Download Options